Abstract -Inmiunochemical methods for the assay of steroid hormones firet commenced in the form of radioinununoaeeay in 1969. This aesay haa been exteneively used during the laet ten years, transforming the field of clinical chemistry. Steroid radioimmunoaeeay can no longer be regarded today e.e a pure research tool, it is emerging as an indiepenaible prac-. tica]. aid to clinical chemistry, the aaeay of steroid hormones being of great value in both routine clinical diagnosis and treatment. The present communication describes research recently pursued in our laboratory, made in order to obtain a clearer understanding of the fundamental principles involved in steroid immunoassay, and to out down the cost of the assays.
A new approach for the correct assessment of specificity is given in detail, and the question of homology and heterology in these types of assay discussed. Our latest research in the development of non-isotope immunoassays is presented with details of conjugation, purification of enzyme labels for enzyme-immunoassay. Immuno-enzymatic assay, fluoroimmunoassay and immunofluorimetric assays developed in London are described, together with a new competitive protein-binding technique for the measurement of femtogram C1015g] amounts of steroids. IN2ODUCTION Steroid radioirnmunoassay has been a revolutionary, development which has been with us for the last ten years. It is now becoming an indispensible aid to the clinical chemist. Unfortun-, ately the many advantages of radioimmunoassay afforded by the use of the all-important highly specific and highly avid iinmunoohemical agent -the antiserum, are being overshadowed by the ever-increasing cost of counting the radiolabel. This has been an impetus for the development of non-isotopic steroid immunoassays. The present communication describes the development of such non-isotopic methods at Queen Elizabeth College, University of London.
Particular emphasis is placed on enzyme-immunoaasay and on a new approach for the correct assessment of the specificity of immunoassay.
STEROID RADIOIMMUNOASSAY

History of development 11
In the early fifties, Yalow and Berson in the U.S.A., whilst studying ' I-labelled proteins, made the discovery that insulin-treated diabetics possessed insulin-binding antibodies.
After initial rejection by their scientific peers with comments such as 'everyone knows that insulin does not make these workers went on to develop, in 1959, a proteinbinding technique for insulin using these (as then questionable) antibodies as the proteinbinding agents (1) . Almost simultaneously, Ekins in Britain, working independently reported a similar method for thyroxine (2) . In the early sixties, it was soon recognized that the general simplicity, the potential sensitivity and the wide applicability of this type of assay, made it the undoubted method of choice for most protein and polypeptide hormones. No single method, particularly in clinical chemistry and endocrinology, was adopted so rapidly and widely as this radioimmunoassay method for proteins. Unfortunately, this valuable technique was not developed for steroids until many years later. Steroid biochemists in the early and mix-sixties did not appreciate that steroids, being haptens, are not antigenic and needed to be coupled to proteins in order to elicit antisteroid antibodies. Undoubtedly it was an irony of fate that despite the work of the great immunologist Landsteiner (who, using this principle had raised antihapten antibodies as early as 1936) and despite the elegant chemical studies in 1957 by Erlanger et al. (3) (who synthesized antigenic steroid-protein conjugates), a decade elapsed between protein and steroid immunoassay development. It was not until 1969 that steroid radioimmunoassay actually commenced when Abraham (k) used an oestradiol-17-17 hemisucoinyl-bovine serum albumin conjugate to elicit antibodies to oestradiol-17. During the next 3 years (1969) (1970) (1971) (1972) investigators 34 DONALD EXLEY raised antieera again.et many steroide, but they invariably conjugated the steroid to the protein carrier via the eteroide' functional groups. The epecificities of the elicited antisera were generally poor with the reault that workers had to nec tedious chromatographic separation prior to the actual radioinimunoaeaay step. During this time, often referred to as the first generation antisera period, it appeared that radioimmunoaaeay had little to offer above the receptor competitive protein-binding techniques of the day. Consequently, radioiinmunoassay of steroids commenced slowly, particularly in Britain. An hypothesis was developed that conjugation of the steroid to protein carriers via a position distal to its functional groups would elicit antibodies of greater specificity than those antibodies raised by conjugation through their functions]. groups. The first indication that this hypo.. thesis was correct was made in our laboratory in 1971 (5) , when my colleagues and I reported on antisera raised by oOetradiol17-6(O..carboxymethyl)-oxiine bovine serum albumin, showing it to be highly specific for oestradiol-17. This was the birth of what has been termed the second generation antisera period. Use of this type of antisera led to simplified types of assay since it obviated the need for tedious chromatographic separations prior to radio-.
imniunoassay. Reasonably specific. competitive protein-binding techniques had now commenced.
Since 1972 the use of high affinity and specific antisteroid sera has enabled simple specific radioimmunoaasays to be made in the lower picogram C1012g] range for most steroids. The main advantages of present-day haptenic (steroid) radioiminunoassay using high specific activity tritium or iodine radioactive labels, are its sensitivity, specificity, precision, practicality and wide applicability. These advantages are well known. Radioinimunoassay is undoubtedly the popular technique of the day in all fields, it is certainly a great success in the steroid field.
Sensitivity
The potential sensitivity of all competitive protein binding methods (of which radioimmunoassay is but one example) is strictly governed by the factor E/ka (6) , where E represents the total error involved in the assay and Ka, in the case of radioimmunoassay, represents the apparent effective equilibrium constant of the heterogeneous collection of antibody sites comprising the antiserum. Let the protein binding agent (or in our case an antibody site) = A, and the hapten or antigen (ligand) i.e. steroid = H. Then:
CA] + [H)
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Acquisition of the tots]. potential sensitivity depends on the specific activity of the labelled steroid. Low specific activity labels will present insensitive assays, despite the fact that 1a may be high. High specific activity labels are usually required for radio-.
inmiunoassay to take full advantage of the potential sensitivity offered by the reasonably high effective Ka of the antiserum used. Immunoassay systems can occur in which the very high specific activity afforded by the label is too sensitive for the Ka presented by the antiserum (see below -enzyme-immunoassay). Thus the higher the Ka of the antiserum used, the higher the sensitivity it affords. Attempts to obtain higher Ka fractions of an anti-.
serum (which may lead to slightly less specificity (7)) by affinity chromatography have invariably failed. The highest recorded Ka for an antiserum against steroids is that for oestradiol-17p at 2 x 1010 litres/mole and this means that with minimum error of assay the limit set for steroids is about 2 picograxns [2 x 102g].
Speoificj
Recent studies in this laboratory regarding the relationship or specificity to affinity of anti-hapten sera (7) have led to an appreciation of a need for a standardized procedure for the assessment of the specificity of antisera. Present-day radioimmunoassay assessment of specificity is unfortunately made under different conditions of radiolabelled tracer binding and of antibody concentration. Data regarding these parameters is invariably not published. Due to this, varying results are obtained for the same antisera in different laboratories. A proposal has therefore been made (8, 9) for the standardization of specificity assessment which enables investigators to verify other workers' results and permit reproducible authentic specificity data to be obtained.
Proposed conditions for secificity assessment
The specificity of an antl8erum is normally assessed by comparing the ability of various cross-reacting ligands against a standard ligand to displace labelled tracer from antibody sites. The relative ability of labelled tracer displacement (relative potency = P) has been calculated for a collection of univalent homogeneous receptor molecules, all of which have the same equilibrium constant (10) . The analytical solution for this idealized case, calculated in terms of the equilibrium constants of labelled tracer (Ks) of standard ligand 
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the reepective molaritiee (molee4itre) of the crose-reacting and standard 1ianda. wflen the equilibrium constant K = K5 (an assumption usually made in radiolemuno-. asee1y), then:
(ii) its standard deviation to be assessed. Assessment of crossreactivities of an individual. antiserum need only involve graphical or mathematical interpretation by calculation on a restricted scale so the operator can satisfactorily process the data manually. Calculation of the ismunoassay results, statistical evaluation of their reliabilitr prior to logit transformation to both standard (linear) plot and the crossreactant (potency weighted) plots; assessment of parameters a, c and Kc can easily be made with the aid of a simple hand calculator. A simple computer programme has been devised in our laboratory to provide the Xc values. Setting K = 1.0, then the ratio K/K0 is equal to the reciprocal of Kc.
once the value of this ratio is known assessment of potency for any practical starting B0 in the actual radioimrnunoassay can be determined from equation (iii).
Standardized conditions of assessment The above method for assessment must be totally standardized. Unfortunately the popular dextran-coated charcoal technique causes dissociation of the antibody-hapten complex, hence disturbing the equilibrium (11), it is therefore proposed that the double antibody precipitation technique be used for this determination of specificity. The amount of antiserum used for the assessment, i.e. concentration of antibody sites, and the amount of radioactive or non-isotopic label must also be standardized. It is essential to work at near saturation of antibody sites, and a proposal has been made (8) that determinations be made using 3/ta moles/litre antibody sites, and the label concentration be k/ta moles4itre where K is the effective apparent equilibrium constant of standard or label, i.e. K5 = (determned by a saturation curve).
Disadvantages of radioissunoasay The use of radio-labelled steroids (or any labelled haptens) has unfortunately, however, a number of disadvantages, not the least of which is expense. Some millions of radioimmunoassays are performed with increasing expense each year. The ever-increasing cost of petroleum based products has seriously increased the cost of liquid scintillant cocktails for counting tritium and also the cost of scintillation vials, and this together with the everrising expense of just maintaining radioactive counters and the cost of isotopes, makes present-day radioiinmunoassay rather expensive. Radioimmunoassay also presents an extra health hazard, particularly when -.emitters are used. In some countries (including France) legislation has been so framed as to prohibit all but a few centres from performing radioimmunoassay. The assay is difficult to automate due to the isotopic counting involved.
It is not surprising that alternative analytical procedures have been considered which take full advantage of the specificity and sensitivity afforded by present-day antisera, but do not employ a radioactive isotope.
ENZYME IMMIJNOASSAY
The most popular alternative label used to date has been an enzyme. Commencing in the early seventies, this enzyme approach pioneered by Schuurs and van Weemen (see their review (13)) has. unfortunately been slow in offering any rem]. competition to radioimmunoasaay.
Steroid methods using this technique have been developed for testosterone, progesterone, and for oestradiol-17; they are probably cheaper methods than radioinununoaasay. Whilst comparable sensitivity to radioimmunoassay has been achieved, the problem of specificity has been particularly perplexing, since up to recently the sensitivity has usually been obtained at the expense of specificity. Recently using judicious heterology (see below) we have been able to overcome this problem enabling us to produce both a sensitive and specific enzyzne-immunoassay for oestradiol-17. Full details of enzyme requirement, steroid.-enzynie conjugate preparation and purification, and the method are presented below.
Criteria for choice of enzyme Reasons for the emphasis given to enzyme labelling are its prior application in histochemistry and cytochemistry, the wide availability and relative inexpensiveness of many enzymes, the prolonged shelf-life of labelled products, the ready existence of manual and automated systems for their assay, freedom from radiation hazards, and a potential sensitivity and specificity as well as an applicability, similar to radioimmunoassay. Many considerations, however, appear to limit the suitability of most enzyinesae potential labels. Considering the rather stringent list of properties required for an idea]. enzyme for enzymeimmunoassay we have; the enzyme should (i) be freely available in a highly purified form at reasonable cost, (ii) have a high specific activity to substrate used which is retained after conjugation to steroid and during storage of the enzyme-steroid complex, (iii) be soluble at pH 6.0 -8.0 for antibody-hapten interaction, (iv) contain several conjugable R groups (usually lysyl), (v) differ from enzymes present in significant concentrations in biological fluids, (vi) the enzyme substrate should be stable and inexpensive, (vii) the enzyme sub-. strate reaction should have an optimum pH that does not impair steroid-antibody binding, (viii) it should afford a simple, rapid, extremely sensitive, reproducible enzyme activity determination using inexpensive freely available equipment.
No enzyme entirely satisfies all these criteria. Two enzymes, more than others, appear to satisfy most of the conditions: E.coli a-D-galactoside-galactohydrolyase (EC 3.2.1.23) and horse-radish peroxidase (EC 1.11.1.7). Both enzymes have been tried in the laboratory, the former galactosidase however has been mainly used, because despite expense it has a higher specific activity to its substrates than the peroxidase.
Enzyme-Steroid conjugation After treatment of the steroid (in the form of a derivative, usually a carboxyl group) with either a carbodiimide such as 1-ethyl-3-(3)-dimethyl-amino-propylcarbodiimide-HC1 (EDC) or alternatively with 1-cyclohexyl-3-(2-morpholinoethyl)carbodiimide-metho-p-..toluene sulphonate (CMC) or by the mixed anhydride method using isobutylchloroformate and tri-N-butylamine, an intermediate is formed which is incubated with the enzyme. This forms a peptide link between the reactive lysyl groups of the enzyme and the carboxyl group of the steroid derivative. After conjugation, the resultant reaction mixture contains several moieties, these are (i) the enzymatically and antigenically active enzyme-steroid conjugate (required product),
(ii) free unconjugated steroid, (iii) free unconjugated enzyme, (iv) antigenically active enzyme-steroid conjugate without enzyme activity, (v) extraneous protein-steroid conjugates (impure enzyme) which make no contribution to enzyme activity, (vi) carbodiimide or mixed anhydride reaction breakdown products. Until recently most enzyme conjugates prepared by investigators have not been rigorously purified prior to their use as enzyme labels. In particular moieties (iii), (iv), and (v) above have not been removed. Investigators using these impure labels have justified their action because automatic purification occurs at the separation stage (i.e. double antibody precipitation, Sepharose, or Microceflulose solid phase systems). Vigorous washing of the precipitate after removal of the supernatant certainly removes free unconjugated enzyme (the greatest hazard). Moieties (iv) and (v), which make no contribution to the enzyme activity are not removed, however they lower the sensitivity of the assay. Consideration however, shows that in order to take full advantage of subsequent ease of automation, it is preferable to take an aliquot of the supernatant for measurement. Impure labels, particularly the presence of large amounts of free unconjugated enzyme, seriously jeopardize this approach since they produce high blanks. 
(15).
The preparation and purification steps used for obtaining this pure conjugate are outlined below. The hapten used for conjugation was oestradiol-17-6-(0-carboxymethyl)oxinie (E26CMO) (Fig.I) : it is synthesized according to (16) . Immunoohemical consideration of the antibody..steroid interaction involved in the enzyme.4mmunoassay shows that maximum sensitivity is achieved by using a I : 1 enzyme/steroid ratio in the conjugate.
Preparation of the conlugate Figure II shows the steps involved in the preparation and purification of the conjugate. The first step was to prepare and extensively purify the enzyme. E.coli mutant K12 3300, cells were cultured and harvested in the normal way and then the cells ruptured in a French press machine. The resultant suspension was centrifuged to remove insoluble material before subjection to 1,0% w/v animonium sulphate precipitation. The crude enzyme was extensively purified by gel filtration on Sepharose 6B.
As stated, the. conjugate was prepared using E2GCMO. Condensation of this compound with lysyl groups of the enzyme to form a peptide link was effected using the carbodiimide CMC. Steroid initnunoassay in clinical chemistry 39 Purification of the conjugate As shown in Fig.II , three eteps are involved in the purification of the crude conjugate (C1). First, the majority of the unconjugated steroid, and carbodiiinide by-products were removed by dialysim, and then last traces by use of a Sephadex GlO column in meries with a ama].).
charcoal column. After this treatment fractiona containing the enzyme were collected and concentrated. This wan the partially purified conjugate (C2). The next purification step involved affinity chromatography to remove non.enzyinicafly active molecules (whether conjugáted to steroid or not) from C2. This conjugate was poured down a column of CH-Sepharose kB.-galaotosylamine which was washed with phosphate-aside salt (PAS) buffer, pH 7.0, until no further protein was detected in the e].uate. The affinity column bound active enzyme was then eluted with 100 mM ga].actose. Fractions containing the active eyme were concentrated and dialysed and provided the partially purified conjugate (C3) . The last step in the purification, one that removes all unconjugated enzyme is a focal one. This again involved affinity chromatography. Antiserum raised against oestrone-6(O-carboxym.thyl)oxime (E16CM0-BSA) which is heterologous to the hapten (26CMO) conjugated to the enzyme was coupled to activated Sepharose kB. In this heterologous affinity cIuomatography technique the affinity of the bound antiserum for the E6CMO moiety of the conjugates was only 10% of that for its homologous hapten (E16CM0), thus excess antibodies were bound to ensure efficient immunoadsorption. This affinity column attracted the enzyme-E26CM0 conjugate only. After immunoadaorption and elution of the free enzyme by PAZ buffer, the bound conjugate was eluted from the column by the stronger affinity homologous hapten E16CM0.
The column fractions containing the conjugate were then concentrated and dia].ysed to remove moat of the E16CM0 eluant, then subjected to Sephadex GlO and charcoal treatment before finally concentrating with polyethylene glycol. This was the fins]. purified conjugate, Ci,.. The enzyme/steroid ratio of the purified conjugate was assessed by acid hydrolysis to be I : 1.7. The conjugate had an enzyme specific activity of 320 uM/mgJmin. towards the synthetic substrate O-nitrophenyl.4-D-galactoside (ONP-G) used for assessing its activity.
An antiserum elicited by oestradiol-17-3-hemisuccinate (E2-3H3-BSA) ( and incubating for 20 mm. at 370 C in a thermostatically-controlled waterbath. The reaction was stopped by the addition of I ml 1.0 N sodium carbonate solution. The amount of hydrolysed substrate was estimated by measuring A1,< mm. A radioimnmunoassay method was set up using exactly the same conditions as above1 except that the enzyme label was replaced by its calculated equivalent of 12.7 pg (2,k,6,7_H)_ oestradiol-I7 and the performance of both immunoassays compared (Fig.III) . Various doses of oestradiol-17, ranging from 50 to 500 pg were added to human male plasma extracted with ether and assayed by both innnunoassay procedures. Almost identical results were obtained from these methods indicating that the enzyme-imnmunoaasay technique could be used to assay human plasma samples.
The described oestradiol-17 method involves probably the simplest, most sensitive and specific enzyme-immnunoassay technique yet produced. The high sensitivity of the enzymeimmunoassay method can be mainly attributed to the use of the high specific activity enzyme and the preparation and purification of the low molar ratio enzyme-steroid conjugate used as immnunoassay label. Factors involved in the preparation and purification procedures which helped to preserve the enzyme activity of the conjugate and therefore the sensitivity of the immunoassay, are the mild enzyme-steroid conjugation technique which did not cause any loss of enzyme activity, and the affinity chromatography purification step which still preserved this activity. Again the affinity chromatography step removed all unconjugated enzyme and thus eliminated any background enzyme activity, which if not removed would interfere with enzyme immunoassay by increasing the blank, hence lowering the sensitivity. Another factor in the enzyme-immnunoaasay method affecting sensitivity is the use of the double antibody precipitation separation procedure, which unlike solid phase methods is not only simple, but the immune precipitate does not interfere with enzyme activity. Alternative assessment of the Lcoli 3-D-galaetosidase activity by its more sensitive synthetic fluorogenic substrate methyluinbelliferyl--D-ga].actoside was found to be too sensitive for the enzyme-immunoassay endpoint determination. Since the limit of sensitivity of any immunoassay method is dictated by the apparent effective equilibrium constant (Ka) of the heterogenous antibody collection with the antigen or hapten (6) this means that use of higher Ka antiserum should enable determination of oestradiol-17 at sub-picogram levels. This is one of the rare occasions when the measurement of the labelled tracer has been recorded as being too sensitive for immunoassay at picogram levels. The simple automatable colorimetric measurement of enzyme activity using a standard laboratory spectrophotometer and an inexpensive readily available substrate, makes the enzyme-immunoassay method cheaper and possibly simpler than radioimmunoassay. These desirable advantages, coupled with the fact that the enzyme-imrnunoassay method is just as sensitive and specific as radioimmunoassay methods for oestradiol..17, possessing freedom from radiation hazard and using an enzyme label superior to radioactive labels as regards shelf-life, all makes the enzymeiminunoassay method more than a serious rival to radioimmunoassay. This type of approach may well become a very popular technique of the future.
Homolo and heterology in enzyme-immunoassa,y As previously stated steroid radioimmunoassay is based on the fundamental principle that the apparent effective Ka of the antiserum used is identical for the radioactively-labelled steroid and the standard or endogenous steroid to be measured. Doubts are obviously cast that exact equivalence of Ka's can ever really be obtained. Tritiated labelled steroids, however, certainly have a very similar Ka towards an antiserum as unlabelled steroids. Unfortunately most other types of labelled steroid can seldom achieve this near equivalence and enzyme labels can be particularly affected. Antigenic recognition of the chemical IA EIA bridge ueed to conjugate the eteroid to the enzyme and the amino acid (usually lysine) in.
volved in the conjugation, will make the Ka between the antieerum used and the inzymeconjugate label higher than the Ka between antiserum and unconjugated steroid. Matters become even more serious when the molar ratio of steroid/enzyme is>1.O, since then the Ka becomes greater the number of steroids conjugated. If the antiserum raised by an antigen in which the protein carrier is conjugated to the steroid by a similar chemical bridge at the same site and to the same amino acid, is used in enzyine-immunoassay to that used to conjugate steroid to enzyme, we have a condition which has been described by previous workers as homologous enzyme-imnmnoassay (18) . When the antiserum used is reasonably specific for the steroid, this condition leads to specific, yet relatively insensitive enzyme-immunoassay.
To overcome this lack of sensitivity, past workers have decreased the Ka the steroidenzyme conjugate to the antiserum. This was generally achieved by using a steroid derivative for the preparation of the enzyme-conjugate which differed from the derivative used for eliciting the antiserum. This has been termed heterologous enzyme-irnmunoassay.
As expected the sensitivity of the enzyme-immunoassay is increased by this approach, however in the past the methods have invariably been less specific, rendering them poor competitors to radioinununoaseay. The enzyme-conjugate label used in enzyme-immunoassay has an apparent effective equilibrium constant towards the antiserum used in the assay which has been defined as Ke (9), thus in this case Ke ' K8 Kce, where the latter Kce represents a crossreactant in enzyme-immunoassay. Attempts to obtain reproducible specificity using the procedure presented above for radioimmunoassay thus leads to difficulty. Direct determination of relative potency using the previously described principles is not possible with enzymeinnnunoassay since K5 Ke no linear logit plots can be obtained for Xe. When the use of radioactive labels is permitted then this problem can be solved by radioirnmunoassay (9), however without such isotopic labels, since the enzyme label K must be assessed using another moiety with the same equilibrium constant it is necessary to use an enzyme label, whose enzyme activity is pez'manently inhibited by active site directed conjugated inhibition.
The inhibited enzyme-steroid complex is then allowed to compete with the active enzymesteroid label as in normal immunoassay, using a limited amount of the active enzyme label. The immunoassay can now be constructed and transformed into a linear logit-log plot. Crossreactions in enzyme-immunoassay (Kce) can now be obtained using equation (vi) above.
The E6CMO-E.coli--D-ga].actosidaee label used in our enzyme-immunoassay method for oestradiol-17 used a specific E-3HS-BSA elicited antiserum in the assay. This combination which involves both site and chemical bridge heterology, allows specificity to be preserved without loss of sensitivity, enabling one of the most specific and sensitive enzymeimmun9aasay methods yet developed to be produced. Assessments made showed that the Ke of the enzyme label in this case was of a similar magnitude to K5 (presented by oestradiol -17) for the antiserum. This suggests that the (O..carboxymetbyl)oxime bridge was not antigenical].y recognized. Results therefore suggest that a judicious choice of either chemical bridge, site of attachment, or both types of heterology made to lower the K of the enzymeimmunoassay label to a similar magnitude to that presented by the antiserum of the steroid to be measured, produces specific and sensitive assay provided the antiserum used is specific for the steroid. Specificity is always dictated by the antiserum used, no amount of heterology will produce specificity from a non-specific antiserum. This approach now enables enzyme-immunoassays to be developed which can be serious rivals to the established costly radioimmunoassay techniques of the day. Provided with the enzyme label, these techniques can certainly be much cheaper than radioimmunoassay. The problem of obtaining authentic reproducible specificity data has undoubtedly been with us ever since Berson and Yalow's first radioimmunoassay method, and it is probably equally true that unbeknown to us we have had to live with heterology and homology for the same period of time. Certainly this latter problem became much more serious at the beginning of the present decade, slowing down the rapid development of specific and sensitive enzyme-immunoassay.
Labelling of hap.. with the use of the most powerful fluorimeter, hardly reaches the required sensitivity, so we have used multi-labelling. This approac'h has been achieved by the use of various carrier molecules which allow not only the attachment of the steroid, but also many molecules of fluorescent label. Applying this idea, fluoroimrnunoassay techniques have been developed for 5a-dihydrotestosterone (5aDHT) (19, 20) , and oestradiol-17 (19) , using k-methylumbelliferyl-3-acetic acid as fluorogenic label. Methods involved the synthesis of 3-amino-5&DHT and 6-amino-oestradio1..17. These amino steroids were conjugated to the lone terminal carboxyl in purifying large amounts of specific steroid antibodies and the fact that labelling the hapten offers similar advantages and less work is involved in preparing the label. A study made in this laboratory has indicated that in general the anti-oestradio].-17 antibodies in a good antiserum raised by E2GCMO-BSA is less than 3% when expressed as a percentage of the total iinmunoglobu]in present. This specific fraction was isolated by affinity chromatography on A}I-Sepharose kB (hexamethylenediarnine spacer) conjugated to E26CM0. The fraction was then labelled with E.coli--D-galactosidase (unfortunately being such a large enzyme only one bould be incorporated). This anti-steroid enzyme complex was then used in an iminunoassay system in which competition of free steroid and steroid bound to Sepharose kB occurs. The distribution of the anti-steroid enzyme complex between the solid phase-linked hapten and the free hapten depends on the concentration of the latter.
Another approach recently used has been to enzyme label donkey (anti-rabbit) antibodies.
This antiserum is the second antibody precipitant of the first antibody in the norma]. double antibody precipitation technique. Immunoaffinity chromatography, using rabbit IgG coupled to Sepharose kB, was employed in the purification of these donkey (anti-rabbit) antibodies. In thi5 inununoenzymatic assay it i the second antibody-enzyme complex in the bound fraction which corresponds to the level of the first antibody in that fraction. The level of sensitivity achieved using 0-nitrophenol galactoside as enzyme substrate approached 50 pg (50 x 10-12 g) in both of these immunoenzymatic methods, so they were not quite as sensitive as radioimmunoassay. As far as steroid immunoassay techniques are concerned it is at present difficult to see any practical advantages of immunoenzymatic methods over haptenlabelled enzyme-iminunoassay, particularly due to the difficulty of isolating reasonable amounts of antibody. The double antibody immunoenzymatic method has, however, the advantage over immunoenzymatic techniques (where the individual steroid antibody is labelled), in that only one species of antiserum needs to be labelled, so it can be used for all steroids and even polypeptide antigens, so this approach could probably have some impact on the steroid field in the future.
Consideration shows that it is better to use a smaller molecular weight enzyme (such as horse-radish peroxidase) for labelling antibodies when probably six or more enzymes may be conjugated per antibody molecule. Enzyme labelling is preferable to fluorogenic labelling. ase per IgG molecule would potentially give 3.58 x 10' molecules of k-mithlumbelliferone per sin. If, as usual, a 10 mm. incubation time was used, then 3.58 x 10° molecules of k.-inethylumbelliferone would be produced, i.e. 2.23 x IO5 times more sensitive than the fluoroimmunoassay end point. Labelling of the antibody (innoradiotric, immunoenzymatic, immunofluorometric assays) allows equivalence of Ka of label and endogenous eteroid or standard oince all heterology and homology is obviated. Problems axiae however, when one has of necessity for assay to distinguish free unoccupied antibodiem from steroid-bound antibodies. The only solution at the moment for rapid assay is to immobilize on a solid phase, either antibody or steroid, and this introduces the problem of heterology. More sophisticated approaches such as antibody spin-labelling or use of antibody compliment may overcome this problem, however they lead to complicated methods.
EIZYME INHIBITION IMMUNOASSAY
A variant of enzyme-immunoassay now used for drugs, biown as enzyme inhibition immunoassay, which is trade-named EMIT (enzyme multiplied immunoassay technique) by its pioneers at S!VA Pharmaceutical Company in California, probably offers a new approach for steroid innnunoassay. Present-day techniques using this approach for drug determinations are far too insensitive for steroid determinations, but research to improve the sensitivity (at present suitable for micrograms and not picogranis) is now being actively pursued in our department. This approach invariably operates by allosteric modification of the active site of an enzyme when an antibody binds to haptens conjugated on this euzyme. The separation stage necessary in all the above previous iminunoassay systems described that of separating antibody-bound hapten from free hapten is obviated. This enables direct assays to be performed in just a few minutes.
SUB-PICOGRAM STEROID ASSAY
Serious problems beset the veterinary clinical chemists of the day regarding levels of residun]. anabolic steroids in animal meat tissues after growth promoter treatments. Steroid levels have to be measured at the sub-picogram level. The highest Ka to TflSfl i.S that produced when the protein Avidin binds its natural ligand Biotin. This Ka i.5 1015 litres! mole and is 50,000 times higher than that recorded for anti-steroid serum. As stated radioinununoassay has a limit of 2 pg [6 x M oestrogenj. Thus the Avidin-Biotin has a potential sensitivity capable of measuring 1.2 x iO.'19 M (20,000 molecules). Work has recently commenced in this laboratory to utilize this system, since up to the date of starting, the only method reported is that using 1251-Biotin for measuring Biotin in plasma over the same range as radioimmunoassay. The very high potential sensitivity afforded by the Avidin-Biotin system has never been harnessed for assay. The binding of Biotin to Avidin has, however, been extensively examixted, and findings strongly suggest that chemical modification or conjugation to the terminal carboxyl group of Biotin does not effect its binding to Avidin. This is indeed fortuitous since it means that any chemical moiety can be conjugated to Biotin and the resultant complex will have the same high Ka of 10'5 L/t4 to Avidin as its natural ligand Biotin. Thus Biotin-steroid conjugates have the same high Ka; and competitive protein binding systems are being developed in the department for such steroid conjugates. A system using labelled bioctin has already been developed (22) which allows measurements of steroid down to +0 x 102 g (i.e. 50 times more sensitive than radioimniuno.. assay) and at present we are attempting to perfect an enzyme-labelled competitive protein binding system using E.coli--D-galactosidase, which will enable measurement in the 1001000 attogram (10-1 G) range.
